tiprankstipranks
Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ:VNDA
US Market

Vanda (VNDA) Income Statement

658 Followers

Vanda Income Statement

Last quarter (Q4 2025), Vanda's total revenue was $57.22M, an increase of 7.58% from the same quarter last year. In Q4, Vanda's net income was $-141.19M. See Vanda’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 216.10M$ 198.77M$ 192.64M$ 254.38M$ 268.68M
Gross Profit
$ 203.06M$ 187.46M$ 177.84M$ 230.10M$ 243.05M
Operating Expenses
$ 354.23M$ 228.12M$ 191.80M$ 223.77M$ 200.89M
Depreciation and Amortization
$ 11.92M$ 8.13M$ 3.01M$ 2.73M$ 2.84M
EBITDA
$ -139.25M$ -32.53M$ -10.94M$ 9.06M$ 45.01M
Operating Income
$ -151.17M$ -40.66M$ -13.95M$ 6.33M$ 42.16M
Other Income/Expenses
$ 12.52M$ 17.74M$ 20.29M$ 4.97M$ 199.00K
Pretax Income
$ -138.65M$ -22.92M$ 6.34M$ 11.30M$ 42.36M
Net Income
$ -220.47M$ -18.90M$ 2.51M$ 6.28M$ 33.15M
Per Share Metrics
Basic EPS
$ -3.74$ -0.32$ 0.04$ 0.11$ 0.60
Diluted EPS
$ -3.74$ -0.32$ 0.04$ 0.11$ 0.58
Weighted Average Shares Outstanding
58.93M 58.15M 57.38M 56.46M 55.55M
Weighted Average Shares Outstanding (Diluted)
58.93M 58.15M 57.56M 56.98M 56.92M
Currency in USD

Vanda Earnings and Revenue History